NanoViricides Net Cash Flow or Change in Cash and Cash Equivalents vs Net Cash Flow from Investing Analysis

NNVC Stock  USD 1.16  0.03  2.65%   
Trend analysis of NanoViricides balance sheet accounts such as Accounts Payable of 274 K provides information on NanoViricides' total assets, liabilities, and equity, which is the actual value of NanoViricides to its prevalent stockholders. By breaking down trends over time using NanoViricides balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.

About NanoViricides Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of NanoViricides at a specified time, usually calculated after every quarter, six months, or one year. NanoViricides Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of NanoViricides and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which NanoViricides currently owns. An asset can also be divided into two categories, current and non-current.

NanoViricides Balance Sheet Chart

NanoViricides Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how NanoViricides uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, NanoViricides' Accounts Payable is projected to decrease significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 14 M, whereas Total Current Liabilities is forecasted to decline to about 583.7 K.

Total Current Liabilities

Total Current Liabilities is an item on NanoViricides balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NanoViricides are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents NanoViricides obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NanoViricides are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Most indicators from NanoViricides' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NanoViricides current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.At present, NanoViricides' Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation723.3K747.5K859.7K772.2K
Interest Income11.9K355.8K409.2K429.7K

NanoViricides fundamental ratios Correlations

0.47-0.180.090.460.37-0.35-0.130.220.37-0.060.230.090.18-0.120.110.23-0.120.130.26-0.09-0.110.380.330.08-0.39
0.470.110.120.00.21-0.4-0.140.440.230.270.520.38-0.030.160.39-0.030.160.120.020.040.150.290.220.35-0.02
-0.180.11-0.36-0.05-0.370.160.430.44-0.330.910.420.63-0.850.790.66-0.050.790.390.170.40.790.56-0.430.610.89
0.090.12-0.360.160.79-0.83-0.960.340.81-0.090.52-0.6-0.070.14-0.590.550.140.52-0.33-0.840.14-0.330.83-0.62-0.21
0.460.0-0.050.160.41-0.22-0.14-0.010.4-0.060.08-0.38-0.140.07-0.360.630.070.260.24-0.390.080.420.31-0.39-0.21
0.370.21-0.370.790.41-0.75-0.810.061.0-0.230.33-0.440.08-0.08-0.450.46-0.080.3-0.23-0.69-0.08-0.140.99-0.47-0.35
-0.35-0.40.16-0.83-0.22-0.750.88-0.41-0.79-0.07-0.620.220.12-0.170.2-0.45-0.17-0.490.090.74-0.170.08-0.770.270.18
-0.13-0.140.43-0.96-0.14-0.810.88-0.22-0.820.19-0.430.58-0.02-0.010.58-0.51-0.01-0.410.230.89-0.010.37-0.850.630.33
0.220.440.440.34-0.010.06-0.41-0.220.080.770.930.15-0.640.810.210.440.810.86-0.32-0.070.810.40.040.130.4
0.370.23-0.330.810.41.0-0.79-0.820.08-0.20.36-0.420.05-0.05-0.430.46-0.050.31-0.19-0.71-0.05-0.130.99-0.46-0.31
-0.060.270.91-0.09-0.06-0.23-0.070.190.77-0.20.730.51-0.90.940.560.150.940.67-0.030.250.940.54-0.290.490.84
0.230.520.420.520.080.33-0.62-0.430.930.360.730.09-0.670.80.150.490.80.89-0.31-0.260.80.330.310.060.38
0.090.380.63-0.6-0.38-0.440.220.580.15-0.420.510.09-0.180.191.0-0.630.19-0.160.250.740.180.37-0.450.990.5
0.18-0.03-0.85-0.07-0.140.080.12-0.02-0.640.05-0.9-0.67-0.18-0.96-0.23-0.41-0.96-0.740.010.05-0.96-0.470.15-0.14-0.79
-0.120.160.790.140.07-0.08-0.17-0.010.81-0.050.940.80.19-0.960.250.41.00.82-0.13-0.011.00.45-0.140.170.78
0.110.390.66-0.59-0.36-0.450.20.580.21-0.430.560.151.0-0.230.25-0.570.25-0.10.240.730.240.43-0.470.980.51
0.23-0.03-0.050.550.630.46-0.45-0.510.440.460.150.49-0.63-0.410.4-0.570.40.71-0.27-0.670.410.360.39-0.68-0.18
-0.120.160.790.140.07-0.08-0.17-0.010.81-0.050.940.80.19-0.961.00.250.40.82-0.13-0.011.00.45-0.140.170.78
0.130.120.390.520.260.3-0.49-0.410.860.310.670.89-0.16-0.740.82-0.10.710.82-0.35-0.350.830.370.25-0.20.35
0.260.020.17-0.330.24-0.230.090.23-0.32-0.19-0.03-0.310.250.01-0.130.24-0.27-0.13-0.35-0.01-0.140.02-0.230.230.1
-0.090.040.4-0.84-0.39-0.690.740.89-0.07-0.710.25-0.260.740.05-0.010.73-0.67-0.01-0.35-0.01-0.020.28-0.710.80.35
-0.110.150.790.140.08-0.08-0.17-0.010.81-0.050.940.80.18-0.961.00.240.411.00.83-0.14-0.020.45-0.140.160.77
0.380.290.56-0.330.42-0.140.080.370.4-0.130.540.330.37-0.470.450.430.360.450.370.020.280.45-0.260.340.19
0.330.22-0.430.830.310.99-0.77-0.850.040.99-0.290.31-0.450.15-0.14-0.470.39-0.140.25-0.23-0.71-0.14-0.26-0.48-0.37
0.080.350.61-0.62-0.39-0.470.270.630.13-0.460.490.060.99-0.140.170.98-0.680.17-0.20.230.80.160.34-0.480.52
-0.39-0.020.89-0.21-0.21-0.350.180.330.4-0.310.840.380.5-0.790.780.51-0.180.780.350.10.350.770.19-0.370.52
Click cells to compare fundamentals

NanoViricides Account Relationship Matchups

NanoViricides fundamental ratios Accounts

201920202021202220232024 (projected)
Other Current Liab630.8K55.8K260.1K377.2K433.8K706.2K
Total Current Liabilities2.2M351.1K412.8K534.3K614.4K583.7K
Total Stockholder Equity21.8M29.9M23.1M14.9M17.1M15.3M
Retained Earnings(105.6M)(114.4M)(122.5M)(131.1M)(118.0M)(112.1M)
Accounts Payable380.7K200.0K58.0K157.1K141.4K274.0K
Common Stock Total Equity69.2K76.9K9.1K11.5K10.4K9.8K
Common Stock Shares Outstanding5.6M10.9M11.5M11.6M13.4M14.0M
Other Stockholder Equity127.3M144.3M145.6M145.9M167.8M176.2M
Total Liab2.2M351.1K412.8K2.0M2.3M4.3M
Accumulated Other Comprehensive Income(3.2M)(3.9M)(4.6M)(5.0)(4.5)(4.73)
Common Stock9.1K11.5K11.6K116.0104.499.18
Total Assets23.9M30.3M23.5M16.9M19.4M20.7M
Property Plant And Equipment Net9.5M9.1M8.7M8.1M9.3M6.2M
Net Debt(12.6M)(20.4M)(14.0M)(8.1M)(7.3M)(7.7M)
Cash13.7M20.5M14.1M8.1M9.4M13.7M
Non Current Assets Total9.9M9.4M9.1M8.5M9.7M6.7M
Non Currrent Assets Other25.9K3.5K42.4K14.4K12.9K12.3K
Cash And Short Term Investments13.7M20.5M14.1M8.1M9.4M13.7M
Liabilities And Stockholders Equity23.9M30.3M23.5M16.9M19.4M20.7M
Non Current Liabilities Total1.5M295.3K152.7K1.5M1.4M1.3M
Other Current Assets277.1B307.1B350.0K295.5K339.8K322.8K
Property Plant And Equipment Gross9.5M9.1M14.7M14.8M17.0M17.9M
Total Current Assets14.0M20.8M14.4M8.4M9.7M14.1M
Intangible Assets358.4K350.1K341.8K333.6K383.6K357.5K
Property Plant Equipment9.5M9.1M8.7M8.1M9.3M8.4M
Net Tangible Assets21.4M29.6M22.7M14.5M16.7M22.0M
Net Invested Capital22.9M30.0M23.2M14.9M17.1M22.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for NanoViricides Stock analysis

When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Return On Assets
(0.36)
Return On Equity
(0.58)
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.